These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 7561633

  • 1. Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess.
    Giustina A, Bussi AR, Deghenghi R, Imbimbo B, Licini M, Poiesi C, Wehrenberg WB.
    J Endocrinol; 1995 Aug; 146(2):227-32. PubMed ID: 7561633
    [Abstract] [Full Text] [Related]

  • 2. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
    Massoud AF, Hindmarsh PC, Brook CG.
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
    [Abstract] [Full Text] [Related]

  • 3. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
    Arvat E, Gianotti L, Grottoli S, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
    [Abstract] [Full Text] [Related]

  • 4. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
    Massoud AF, Hindmarsh PC, Matthews DR, Brook CG.
    Clin Endocrinol (Oxf); 1996 May; 44(5):555-62. PubMed ID: 8762732
    [Abstract] [Full Text] [Related]

  • 5. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.
    Popovic V, Micic D, Djurovic M, Obradovic S, Casanueva FF, Dieguez C.
    Clin Endocrinol (Oxf); 1997 May; 46(5):539-43. PubMed ID: 9231048
    [Abstract] [Full Text] [Related]

  • 6. Hypothalamic control of growth hormone (GH) secretion in type I diabetic men: effect of the combined administration of GH-releasing hormone and hexarelin, a novel GHRP-6 analog.
    Giustina A, Desenzani P, Perini P, Deghenghi R, Bugari G, Wehrenberg WB, Giustina G.
    Endocr Res; 1996 May; 22(2):159-74. PubMed ID: 8799695
    [Abstract] [Full Text] [Related]

  • 7. Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment.
    Giustina A, Girelli A, Bossoni S, Legati F, Schettino M, Wehrenberg WB.
    Metabolism; 1992 May; 41(5):548-51. PubMed ID: 1375312
    [Abstract] [Full Text] [Related]

  • 8. Modulation of growth hormone-releasing activity of hexarelin in man.
    Arvat E, Gianotti L, Di Vito L, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F, Ghigo E.
    Neuroendocrinology; 1995 Jan; 61(1):51-6. PubMed ID: 7731498
    [Abstract] [Full Text] [Related]

  • 9. Metabolic modulation of the growth hormone-releasing activity of hexarelin in man.
    Maccario M, Arvat E, Procopio M, Gianotti L, Grottoli S, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F, Ghigo E.
    Metabolism; 1995 Jan; 44(1):134-8. PubMed ID: 7854159
    [Abstract] [Full Text] [Related]

  • 10. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
    Micic D, Popovic V, Kendereski A, Peino R, Dieguez C, Casanueva FF.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750
    [Abstract] [Full Text] [Related]

  • 11. Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy.
    Giustina A, Bossoni S, Bodini C, Girelli A, Balestrieri GP, Pizzocolo G, Wehrenberg WB.
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1301-5. PubMed ID: 1592874
    [Abstract] [Full Text] [Related]

  • 12. Different effects of growth hormone releasing peptide (GHRP-6) and GH-releasing hormone on GH release in endogenous and exogenous hypercortisolism.
    Borges MH, DiNinno FB, Lengyel AM.
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):713-8. PubMed ID: 9274702
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.
    Ghigo E, Arvat E, Gianotti L, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F.
    J Clin Endocrinol Metab; 1994 Mar; 78(3):693-8. PubMed ID: 8126144
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M, Bossoni S, Alí A, Doga M, Reimondo G, Milani G, Peretti P, Manelli F, Angeli A, Giustina A.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or pretreatment with pirenzepine.
    Rigamonti AE, Marazzi N, Cella SG, Cattaneo L, Müller EE.
    J Endocrinol; 1998 Feb; 156(2):341-8. PubMed ID: 9518881
    [Abstract] [Full Text] [Related]

  • 16. Hexarelin, a novel GHRP-6 analog, counteracts the inhibitory effect of hydrocortisone on growth hormone secretion in acromegaly.
    Giustina A, Bresciani E, Bugari G, Bussi AR, Deghenghi R, Imbimbo B, Giustina G.
    Endocr Res; 1995 Aug; 21(3):569-82. PubMed ID: 7588427
    [Abstract] [Full Text] [Related]

  • 17. Hexarelin induced growth hormone release is influenced by exogenous growth hormone.
    Massoud AF, Hindmarsh PC, Brook CG.
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):617-21. PubMed ID: 8548947
    [Abstract] [Full Text] [Related]

  • 18. Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients.
    Ciccarelli E, Grottoli S, Razzore P, Gianotti L, Arvat E, Deghenghi R, Camanni G, Ghigo E.
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):67-71. PubMed ID: 8706295
    [Abstract] [Full Text] [Related]

  • 19. Hexarelin, a synthetic GH-releasing peptide, is a powerful stimulus of GH secretion in pubertal children and in adults but not in prepubertal children and in elderly subjects.
    Bellone J, Bartolotta E, Sgattoni C, Aimaretti G, Arvat E, Bellone S, Deghenghi R, Ghigo E.
    J Endocrinol Invest; 1998 Sep; 21(8):494-500. PubMed ID: 9801989
    [Abstract] [Full Text] [Related]

  • 20. Acute administration of hexarelin stimulates GH secretion during day and night in normal men.
    Loche S, Colao A, Cappa M, Ferone D, Merola B, Faedda A, Imbimbo BP, Deghenghi R, Lombardi G.
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):275-9. PubMed ID: 9156035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.